Bill Gates and Jeff Bezos have invested more than $100 million in a new cancer test.<\/p>\n
Grail, the company developing the test, said on Tuesday in Beijing that the method was a universal blood test to identify early-stage cancers in people with no symptoms.<\/p>\n
Jay Flatley, Illumina Chief Executive, who would serve as chairman of Grail, said the technology was aimed at detecting newly-forming cancers, and treat them at an earlier stage to increase the chances of survival.<\/p>\n
He said the company started this new test 18 months ago, and that it was estimated to take at least an additional year of research and development to refine it.<\/p>\n
Flatley said the process was being carried out through a technique called a “liquid biopsy.”<\/p>\n
“It scans patients’ blood streams for signs of cancer DNA, which can indicate that a tumor is forming, even if a doctor can’t see it on a scan and the patient hasn’t experienced any symptoms,\u201d he said. <\/p>\n
Follow Us<\/p>\n